{"url_path":"/sec/rkda/8-k/2026-07-02/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-02","source_url":"https://www.sec.gov/Archives/edgar/data/1469443/0001193125-26-294619-index.html","accession_number":"0001193125-26-294619","cik":"0001469443","ticker":"RKDA","issuer_name":"Arcadia Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1469443/0001193125-26-294619-index.html","primary_entity_key":"0001469443","primary_entity_name":"Arcadia Biosciences, Inc."},"word_count":101,"has_tables":true,"body_markdown":"## Item 8.01 Other Events.\n\nThe information in Item 5.08 above concerning the Company's 2026 Annual Meeting and the date for stockholders to submit nominations for director or proposals to be considered for inclusion in the Company's proxy statement relating to the 2026 Annual Meeting is hereby incorporated by reference into this Item.\n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\nARCADIA BIOSCIENCES, INC.\n\n \n\n \n\n \n\n \n\nDate:\n\nJuly 2, 2026\n\nBy:\n\n/s/ Thomas J. Schaefer\n\n \n\n \n\n \n\nThomas J. Schaefer, Chief Executive Officer"}